v3.26.1
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Operating activities:    
Net income (loss) $ 2,963 $ (3,914)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 9,954 6,878
Stock-based compensation expense 13,554 17,225
Amortization of deferred financing costs 434 62
Loss on extinguishment of debt 17 0
Cost of Phreesia hardware purchased by customers 188 436
Deferred contract acquisition costs amortization 116 110
Non-cash operating lease expense 233 215
Deferred taxes 677 85
Changes in operating assets and liabilities:    
Accounts receivable 7,731 (1,490)
Cash received for sale of receivables 7,711 0
Accrued interest receivable 129 0
Prepaid expenses and other assets 828 (256)
Accounts payable 159 (1,739)
Accrued expenses and other liabilities (6,985) (891)
Payment of due to provider for receivables sold to securitization (5,060) 0
Lease liabilities (410) (252)
Deferred revenue (8,317) (1,619)
Net cash provided by operating activities 23,922 14,850
Investing activities:    
Collections of cardholder receivables held for investment and deferred purchase price 12,352 0
Capitalized internal-use software (3,240) (3,888)
Purchases of property and equipment (4,310) (3,504)
Net cash provided by (used in) investing activities 4,802 (7,392)
Financing activities:    
Proceeds from issuance of common stock upon exercise of stock options 131 128
Treasury stock to satisfy tax withholdings on stock compensation awards (1,095) 0
Proceeds from employee stock purchase plan 522 768
Finance lease payments (1,680) (1,376)
Principal payments on financing agreements (355) (320)
Debt issuance costs and loan facility fee payments (2,259) (38)
Financing payments of acquisition-related liabilities 0 0
Debt extinguishment costs (42) 0
Proceeds from debt instruments 92,240 0
Principal payments on debt instruments (98,000) 0
Payments due to provider for unfunded receivables (15,555) 0
Net cash used in financing activities (26,093) (838)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (64) 31
Net increase in cash, cash equivalents and restricted cash 2,567 6,651
Cash, cash equivalents and restricted cash – beginning of period 73,830 84,220
Cash, cash equivalents and restricted cash – end of period 76,397 90,871
Supplemental information of non-cash investing and financing information:    
Non-cash activity related to credit card receivables and deferred purchase price 27,717 0
Exchange of right of use asset for property and equipment 57 0
Purchase of property and equipment and capitalized software included in accounts payable and accrued liabilities 2,304 1,117
Capitalized stock-based compensation 342 332
Issuance of stock to settle liabilities for stock-based compensation 8,053 6,508
Cash paid for:    
Interest 3,848 324
Income taxes 1,181 551
Reconciliation of cash, cash equivalents and restricted cash shown in statements of cash flows    
Cash, cash equivalents and restricted cash per balance sheets 74,706 90,871
Restricted cash included in other long-term assets 1,691  
Total cash, cash equivalents and restricted cash shown in statements of cash flows $ 76,397 $ 90,871